Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) $ in Thousands	Total	Common shares	Treasury Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Balance, beginning of period (in shares) at Jun. 30, 2024		17,017,000
Balance, beginning of period at Jun. 30, 2024	$ 165,799	$ 2	$ (25,367)	$ 210,200	$ (7,913)	$ (11,123)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	7,531					7,531
Foreign currency translation adjustments	1,388				1,388
Changes in fair value of cash flow hedges	379				379
Purchase of treasury shares (in shares)		(282,000)
Purchase of treasury shares	(4,678)		(4,678)
Issuance of common shares (in shares)		30,000
Issuance of common shares	382			382
Stock-based compensation expense	290			290
Balance, end of period (in shares) at Sep. 30, 2024		16,765,000
Balance, end of period at Sep. 30, 2024	$ 171,091	$ 2	(30,045)	210,872	(6,146)	(3,592)
Balance, beginning of period (in shares) at Jun. 30, 2025	13,357,990	13,358,000
Balance, beginning of period at Jun. 30, 2025	$ 134,309	$ 1	(103,338)	218,241	(6,336)	25,741
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	12,042					12,042
Foreign currency translation adjustments	(1,212)				(1,212)
Changes in fair value of cash flow hedges	(2,188)				(2,188)
Purchase of treasury shares (in shares)		(92,000)
Purchase of treasury shares	(2,680)		(2,680)
Issuance of common shares (in shares)		158,000
Issuance of common shares	2,413	$ 1		2,412
Stock-based compensation expense	$ 941			941
Balance, end of period (in shares) at Sep. 30, 2025	13,424,284	13,424,000
Balance, end of period at Sep. 30, 2025	$ 143,625	$ 2	$ (106,018)	$ 221,594	$ (9,736)	$ 37,783